Impact of the COVID-19 Pandemic on Symptoms of Anxiety Disorders

• Conditions: F40.00; F40.01; F40.1; F41.0; F40.2; Social phobias; Panic disorder [episodic paroxysmal anxiety]; Specific (isolated) phobias

• Registration Number: DRKS00022280
• Lead Sponsor: ehrstuhl für Psychotherapie, Institut für Psychologie, Humboldt-Universität zu Berlin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-07-13
• Study Completion: 2020-10-15
• Results First Posted: 2022-08-18
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 49

Inclusion Criteria

primary diagnosis anxiety disorder

Exclusion Criteria

suicidality, psychotic disorders, substance dependence

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
change of anxiety symptoms measured by evaluated questionnaires.<br><br>Questionnaires:<br>LSAS <br>PAS<br>Fragebogen zu COVID-19 (self made)<br><br>Start of survey: 20.07.2020

Secondary Outcome Measures

Name	Time	Method
mental health measured by evaluated questionnaires<br><br>Questionnaires:<br>PHQ<br>individual questions<br><br>Start of survey: 20.07.2020